Greg, looks like they won't need your 0.01c :)
By the way imo this company has a long road ahead of it and is not a threat to Prima's viability in the foreseeable future.Cheers
Capital Briefs: QBiotics
Amanda Ellis
Thursday, 17 June 2010
IN the wake of a high-profile, well-executed capital raising campaign, QBiotics has raised some $8.1 million to support in-human research into its tumour-reduction drug EBC-46.
By yesterday afternoon, the company had raised $9.4 million from investors and said it expected to close its $10 million in a matter of days.
A representative for the company told BTN the money would help fund Phase 1 and possibly Phase 2 human trials of EBC-46.
The research program is expected to kick off in early 2011.
The capital raising is being managed by QBiotics corporate finance manager Reuben Buchanan.
Funds have come from private individuals and high net worth investors, Buchanan said.
No venture capital or private equity firms have subscribed for any shares in QBiotics.
The company said the success of its raising meant QBiotics now had sufficient funds to complete Phase 1 and potentially part of Phase 2 human trials without the need for a further capital raising.
This reduces risk and minimises potential dilution for shareholders who subscribe to this round. If further capital is required to complete Phase 2, it will be raised at a substantially higher valuation.
www.BiotechnologyNews.net
- Forums
- ASX - By Stock
- no need to be concerned
Greg, looks like they won't need your 0.01c :)By the way imo...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $458.1M |
Open | High | Low | Value | Volume |
32.0¢ | 32.8¢ | 31.0¢ | $1.817M | 5.763M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 71665 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 36363 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 71665 | 0.310 |
17 | 336339 | 0.305 |
21 | 385559 | 0.300 |
4 | 79250 | 0.295 |
8 | 215108 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 36363 | 2 |
0.325 | 297337 | 6 |
0.330 | 97094 | 5 |
0.335 | 164962 | 3 |
0.340 | 110101 | 4 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online